The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

Driving Statistical Innovation - Barriers And Strategies Part 1

Download it: MP3 | AAC | OGG | OPUS
  • The interplay between invention and commercialization for statistical inventions.
  • Potential barriers to success include lack of knowledge/software, resistance to change, and short-term goals over long-term initiatives.
  • Strategies for success include:
    • Clear communication
    • Patience/resilience in long-term initiatives
    • Providing resources/training, promoting diversity/inclusion in teams
    • Networking/communication skills, collaboration with other functions, pragmatism/compromise for success
    • Freedom to innovate
    • Setting up a community of statisticians.

We provide valuable insights into driving statistical innovation, overcoming barriers, and strategic planning. The success of statistical innovation requires clear communication, patience, resilience, collaboration, innovation, and pragmatism. By leveraging external resources and setting up a community of statistical methodology leaders, we can bring value to patients and overcome statistical challenges in the pharmaceutical industry.

Learn more by listening to this episode now and share this with your friends and colleagues!


Comments


New comment

By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.

About this podcast

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.

by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry

Subscribe

Follow us